CUREiculum Webinar Series: Latency Reversing Agents

The CUREiculum is a suite of tools that provides simple, accessible information on HIV cure research. As part of the effort to increase research literacy around cure, the CUREiculum team, a collaboration of community educators, researchers and advocacy organizations, will be presenting a webinar series that focus on issue-specific topics crucial to understanding the research landscape.

Latency Reversing Agents
Thursday March 26th, 4 pm ET

This webinar will feature Dr. David Margolis, Principal Investigator of the CARE Collaboratory at University of North Carolina at Chapel Hill, and Dr. Sharon Lewin member of the DARE Collaboratory and Director of the Infectious Disease department at Monash University. Latency reversing agents are biological compounds used to “wake up” HIV infected cells from their resting state in the body. The drugs are used as the “kick”, the first in a two phase strategy often called “kick and kill”. Both researchers will discuss what latency reversing agents are and how the research might contribute to a combination curative strategy.

Register here for webinar details!

For more information, please contact Jessica or Karine.